全文获取类型
收费全文 | 1088篇 |
免费 | 49篇 |
国内免费 | 13篇 |
专业分类
儿科学 | 14篇 |
妇产科学 | 4篇 |
基础医学 | 100篇 |
口腔科学 | 5篇 |
临床医学 | 133篇 |
内科学 | 604篇 |
皮肤病学 | 4篇 |
神经病学 | 31篇 |
特种医学 | 78篇 |
外科学 | 42篇 |
综合类 | 15篇 |
预防医学 | 50篇 |
眼科学 | 11篇 |
药学 | 35篇 |
肿瘤学 | 24篇 |
出版年
2021年 | 16篇 |
2019年 | 19篇 |
2018年 | 28篇 |
2017年 | 14篇 |
2016年 | 16篇 |
2015年 | 15篇 |
2014年 | 24篇 |
2013年 | 27篇 |
2012年 | 44篇 |
2011年 | 49篇 |
2010年 | 39篇 |
2009年 | 22篇 |
2008年 | 51篇 |
2007年 | 69篇 |
2006年 | 57篇 |
2005年 | 53篇 |
2004年 | 40篇 |
2003年 | 46篇 |
2002年 | 46篇 |
2001年 | 30篇 |
2000年 | 24篇 |
1999年 | 16篇 |
1998年 | 23篇 |
1997年 | 15篇 |
1996年 | 15篇 |
1995年 | 18篇 |
1994年 | 7篇 |
1993年 | 12篇 |
1992年 | 6篇 |
1991年 | 14篇 |
1990年 | 15篇 |
1989年 | 19篇 |
1988年 | 18篇 |
1987年 | 21篇 |
1985年 | 7篇 |
1984年 | 9篇 |
1983年 | 17篇 |
1982年 | 13篇 |
1981年 | 7篇 |
1980年 | 14篇 |
1979年 | 28篇 |
1978年 | 10篇 |
1977年 | 12篇 |
1976年 | 13篇 |
1975年 | 12篇 |
1974年 | 11篇 |
1973年 | 19篇 |
1972年 | 12篇 |
1971年 | 9篇 |
1970年 | 8篇 |
排序方式: 共有1150条查询结果,搜索用时 16 毫秒
1.
2.
Wilbert S Aronow 《Expert opinion on pharmacotherapy》2016,17(2):205-215
Introduction: It is important to know how to treat hypertension in patients with coronary artery disease (CAD). The reason for the review was to update this treatment and to discuss the 2015 American Heart Association/American College of Cardiology/American Society of Hypertension 2015 guidelines of treatment of hypertension in patients with CAD.Areas covered: Studies between 1968 and 2015 were reviewed on treatment of hypertension in patients with CAD using a Medline search, and studies between 1977 and 2015 were reported. Hypertension should be treated with beta blockers and ACE inhibitors or angiotensin receptor blockers (ARBs). Long-acting nitrates are effective antianginal and anti-ischemic drugs. Calcium-channel blockers (CCBs) may be added if angina persists despite beta blockers and long-acting nitrates. The 2015 guidelines recommend that the blood pressure should be < 140/90 mm Hg in patients aged ≤ 80 years and the systolic blood pressure < 150 mm Hg if they are ≥ 80 years.Expert opinion: Hypertension in patients with CAD should be treated with beta blockers and ACE inhibitors or ARBs. Long-acting nitrates are effective antianginal and anti-ischemic drugs. CCBs may be added if angina persists despite beta blockers and long-acting nitrates. The blood pressure should be < 140/90 mm Hg in patients aged < 80 years and the systolic blood pressure < 150 mm Hg if they are ≥ 80 years. 相似文献
3.
Hans D de Boer Jan van Egmond Jacques J Driessen Leo HD Booij 《Neuropsychiatric Disease and Treatment》2007,3(5):539-544
Steroidal neuromuscular blocking agents (NMBAs), such as rocuronium, are widely used in clinical anesthesia and emergency medicine to facilitate endotracheal intubation and artificial ventilation and to allow surgical access to body cavities. Reversal of neuromuscular blockade is important for the acceleration of patient recovery and prevention of postoperative residual neuromuscular blockade and reduces the incidence of severe morbidity and mortality associated with anesthesia management. Sugammadex is the first selective relaxant binding agent (SRBA) and has been designed to reverse the steroidal neuromuscular blocking drug rocuronium. Encapsulation of the rocuronium molecule by sugammadex results in a rapid decrease in free rocuronium in the plasma and subsequently at the nicotinic receptor at the motor endplate. After encapsulation, rocuronium is not available to bind to the nicotinic receptor in the neuromuscular junction. This promotes the liberation of acetylcholine receptors, and muscle activity reappears. This new concept of reversal of neuromuscular block induced by rocuronium (or vecuronium) led to impressive results in animal and phase 1 and 2 studies. Sugammadex is currently in phase 3 clinical studies and may be commercially available by 2008. 相似文献
4.
In vitro and in vivo precipitation of iodinated contrast agents when ioxaglate and papaverine are given together has been reported. To verify these reports and to investigate other medications not previously tested, the authors analyzed mixtures of contrast agents and medications in vitro with a light spectrophotometer and observed them for visible precipitates for up to 120 minutes. Previously reported incompatibilities between ionic or low-osmolality contrast media and medications were verified, and several new incompatibilities were discovered. No incompatibilities were found when the drugs tested were mixed with the new nonionic contrast media. 相似文献
5.
6.
7.
8.
9.
Parental and professional responses to questionnaires evaluating a paediatric disability service are reported and the viability of auditing structural, process, and outcome aspects of clinical practice are discussed. Expectations of waiting time to first appointment (met for only 52% of consumers) illustrate structural issues. Process issues are reflected in consumer reactions to outreach work (for example, 94% of parents and 84% of professionals found this supportive). Outcome measures such as consumer satisfaction with the service (76% of consumers reported being 'very satisfied' and 20% 'fairly satisfied') suggest that service aims are being met. Good concurrence of service aims with consumer needs is indicated by parental reasons for referral (for example, 75% for diagnostic help, 73% for a better understanding of the disorder, 88% for practical help), referrers' reasons (for example, 55% for a second diagnostic opinion, 45% due to lack of local expertise), and reports from most other professionals involved with the case that a similar service was not provided locally. 相似文献
10.
Pattern of Sequence Variation Across 213 Environmental Response Genes 总被引:10,自引:0,他引:10
Robert J. Livingston Andrew von Niederhausern Anil G. Jegga Dana C. Crawford Christopher S. Carlson Mark J. Rieder Sivakumar Gowrisankar Bruce J. Aronow Robert B. Weiss Deborah A. Nickerson 《Genome research》2004,14(10A):1821-1831
To promote the clinical and epidemiological studies that improve our understanding of human genetic susceptibility to environmental exposure, the Environmental Genome Project (EGP) has scanned 213 environmental response genes involved in DNA repair, cell cycle regulation, apoptosis, and metabolism for single nucleotide polymorphisms (SNPs). Many of these genes have been implicated by loss-of-function mutations associated with severe diseases attributable to decreased protection of genomic integrity. Therefore, the hypothesis for these studies is that individuals with functionally significant polymorphisms within these genes may be particularly susceptible to genotoxic environmental agents. On average, 20.4 kb of baseline genomic sequence or 86% of each gene, including a substantial amount of introns, all exons, and 1.3 kb upstream and downstream, were scanned for variations in the 90 samples of the Polymorphism Discovery Resource panel. The average nucleotide diversity across the 4.2 MB of these 213 genes is 6.7 × 10-4, or one SNP every 1500 bp, when two random chromosomes are compared. The average candidate environmental response gene contains 26 PHASE inferred haplotypes, 34 common SNPs, 6.2 coding SNPs (cSNPs), and 2.5 nonsynonymous cSNPs. SIFT and Polyphen analysis of 541 nonsynonymous cSNPs identified 57 potentially deleterious SNPs. An additional eight polymorphisms predict altered protein translation. Because these genes represent 1% of all known human genes, extrapolation from these data predicts the total genomic set of cSNPs, nonsynonymous cSNPs, and potentially deleterious nonsynonymous cSNPs. The implications for the use of these data in direct and indirect association studies of environmentally induced diseases are discussed. 相似文献